3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Peripheral Nervous System Diseases
2
Urinary Bladder Neoplasms
1
Signs and Symptoms
1
Sepsis
1
Sarcoma
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Neoplasms
1
Menstruation Disturbances
1
Febrile Neutropenia
1
Cross Infection
1
Colorectal Neoplasms
1
Interventions
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Cisplatin
4
trastuzumab deruxtecan
3
Platinum
3
Docetaxel
3
Carboplatin
3
Biopsy
3
pembrolizumab
2
entrectinib
2
darolutamide
2
Trastuzumab
2
Radiotherapy, Intensity-Modulated
2
Leuprolide
2
Goserelin
2
Ado-Trastuzumab Emtansine
2
1,2-diaminocyclohexaneplatinum II citrate
2
zanidatamab
1
trastuzumab biosimilar HLX02
1
sacituzumab govitecan
1
pyrotinib
1
pertuzumab
1
luprolide acetate gel depot
1
larotrectinib
1
enfortumab vedotin
1
dehydroftorafur
1
ceralasertib
1
camrelizumab
1
bicalutamide
1
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Salivary Gland Neoplasms
×
Acupuncture Therapy
×
90 days
×
Clear all
No trials found.